相关实验视频

Updated: Jul 14, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

在经皮冠状动脉干预期间使用斑块修饰微导管用于慢性全封闭:来自PROGRESS-CTO注册表的见解

Deniz Mutlu¹, Athanasios Rempakos¹, Michaella Alexandrou¹

¹Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

The Journal of invasive cardiology

|March 12, 2024

概括

斑块修饰微导管 (PM) 很少用于慢性全闭性皮肤冠状动脉干预 (CTO-PCI). 然而,这些设备表现出高的程序成功率和可接受的并发症率,Tornus和Turnpike Gold模型的结果相似.

科学领域:

干预心脏病学干预心脏病学
医疗器械技术医疗器械技术

背景情况:

斑块修饰微导管 (PM) 旨在改变动脉样硬化病变,并在复杂的穿皮冠状动脉干预 (PCI) 期间提供支持.
它们在慢性全闭性PCI (CTO-PCI) 中的特殊作用和利用模式需要进一步研究.

研究的目的:

评估CTO-PCI中与斑块修饰微导管相关的使用频率和临床结果.
为了比较Tornus和Turnpike Gold PM设备的性能.

主要方法:

分析了一个国际多中心注册表.
在CTO-PCI案件中收集和评估了PM设备 (Tornus和Turnpike Gold) 的使用数据.
记录了技术上的成功,程序上的成功,以及主要的不良心脏事件 (MACE).

主要成果:

在242个案例中使用了PM设备 (1.6%的所有CTO-PCI程序),其中Tornus和Turnpike Gold分别使用了51%和49%.
使用频率显示了随着时间的推移下降的趋势.
技术和程序成功率很高,MACE的发病率在两种设备之间是相似的.
使用PM与高成功率和可接受的并发症率有关.

结论:

斑块修饰微导管在CTO-PCI中很少使用.
尽管使用率低,但这些设备与高的程序成功率和可接受的安全配置文件有关.
在这个注册表中,Tornus和Turnpike Gold设备显示了可比的结果.

关键词:

在CTO-PCI中.慢性完全封闭症慢性完全封闭症通过皮肤进行冠状动脉干预.斑块的修改斑块的修改斑块修饰微导管的微导管

更多相关视频

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

Published on: November 22, 2024

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...